NS
Nasus Pharma Ltd.
NSRX · AMEX
$3.45 -2.41% (-$0.09)
1M -13.27%
Piotroski F-Score Weak
2/9Valuation
-
N/A PEG N/A
P/S N/A
P/B N/A
Growth
-
N/A Rev. growth N/A
FCF growth N/A
Book val. growth N/A
Profitability
-
N/A Net margin N/A
Op. margin N/A
FCF margin N/A
Quality
-
N/A ROE N/A
ROA N/A
Asset turnover N/A
Debt
-
N/A Current ratio N/A
Int. coverage N/A
Net debt/EBITDA N/A
Stability
0 /100
Unstable Beta 4.20x
EPS volatility N/A
Profitable years N/A
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about NSRX
Online
Sector
Healthcare
Industry
Medical - Pharmaceuticals
CEO
Brendan O'Grady
Employees
7
Headquarters
Tel Aviv